Blood NfL levels were correlated with abnormalities on brain MRI in MLD [64], GFAP levels in the CSF of AxD patients were consistently elevated [65], and the potential of plasma NfL as a biomarker of spinal cord degeneration in adrenoleukodystrophy has been illustrated [66]. This evidence concerns the gene GFAP and Alexander disease.